Body Pharm TB-500 10 Vial

Body Pharm TB-500 10mg is a single-vial lyophilised research peptide (thymosin beta-4 analogue) that you reconstitute yourself with bacteriostatic water, giving you full control over concentration and dose volume that pre-filled pen formats (like the BodyPharm BPC-157/TB-500 32-pen) simply do not allow.

Key Takeaways

• Lyophilised vial format offers dosing flexibility and lower cost-per-mg (R58.00/mg) compared to pre-filled pens (R78.09/mg blended)
• Reconstitution takes two minutes with bacteriostatic water, an insulin syringe, and alcohol swabs; concentration is your choice
• Storage stability is superior pre-reconstitution (room temperature acceptable) but requires 2–8°C refrigeration after mixing for roughly 28–30 days
• No large-scale human RCT confirms TB-500 efficacy for musculoskeletal repair; evidence remains preclinical and anecdotal
• Research-only status means SAHPRA has not approved it for human therapeutic use; verify regulatory position before purchase
• COA verification (Certificate of Analysis) is available on request and should be checked against your batch number before opening

What Is Body Pharm TB-500 10mg?

Body Pharm TB-500 10mg is a synthetic analogue of Thymosin Beta-4 (TB4), supplied as a lyophilised (freeze-dried) powder in a single sterile vial, priced at R580.00 and sold strictly as a research compound. SAHPRA has not approved it for human therapeutic use, and we could not confirm any SAHPRA registration for it.

Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide that binds G-actin and regulates actin polymerisation. In preclinical models this process has been linked to cell migration, angiogenesis and wound healing. TB-500 is the synthetic peptide fragment used in research settings to investigate those same pathways without sourcing native TB4.

What you are buying, in concrete terms:

• Format: lyophilised powder, single 10mg vial, sealed under vacuum
• Active: TB-500 (thymosin beta-4 fragment analogue)
• Reconstitution: requires bacteriostatic water (sold separately); see the Peptide Reconstitution Calculator for exact volumes
• Price: R580.00 per 10mg vial (BeSkinny, 2026)
• Intended use: in vitro and in vivo research only; not for human consumption
• Lower-quantity option: the Body Pharm TB-500 5mg vial for researchers trialling the compound before scaling up

The research-only framing is not marketing hedge. TB-500 has no SAHPRA registration as a medicine, and the strongest published evidence for musculoskeletal repair remains animal and preclinical.

Lyophilised Vial vs Pre-Filled Pen: Key Differences

The lyophilised 10mg vial wins on cost-per-mg and dosing flexibility. The 32mg pre-filled pen wins on convenience and ready-to-inject speed. Which one suits you depends on whether you value precision and price (vial) or grab-and-go simplicity (pen).

Reconstitution. The Body Pharm 10mg vial ships as dry powder and requires bacteriostatic water plus a syringe before first use. The lyophilised format preserves the peptide in an inert state. The Body Pharm BPC-157 & TB-500 32mg pen arrives pre-mixed and ready to dial a dose.

Dosing flexibility. The vial lets you set any concentration you want. 10 mL of bacteriostatic water yields 1 mg/mL, and 5 mL yields 2 mg/mL. Dose increments are limited only by syringe graduations. The pen delivers fixed-click doses set by the manufacturer, which is faster but inflexible. Use the Peptide Reconstitution Calculator to plan vial concentrations before mixing.

Storage. Lyophilised powder is stable at room temperature before reconstitution and refrigerated (2–8°C) after mixing. The dry state resists moisture-driven degradation. The pen is a pre-mixed liquid and needs refrigeration from the moment it leaves cold-chain transit through to last use.

Cost-per-mg (2026). Body Pharm TB-500 10mg vial at R580.00 works out to R58.00/mg (BeSkinny, 2026). The Body Pharm BPC-157 & TB-500 32mg pen at R2,499.00 works out to roughly R78.09/mg of combined peptide. That figure splits across two actives, so the pure TB-500 cost-per-mg is higher still.

Shelf life after reconstitution. Vendor guidance commonly cites 28–30 days refrigerated, but no TB-500-specific peer-reviewed stability paper confirms that figure. Treat it as a working rule, not a guarantee.

Which format fits which buyer

The vial suits researchers who already own bacteriostatic water, syringes and a calculator, and who want to titrate concentrations across a study. The flexibility allows protocol adjustments mid-research. If you're testing the compound at a smaller scale first, the Body Pharm TB-500 5mg vial is the cheaper entry point.

The pen suits buyers who prioritise convenience, accept a ~35% cost-per-mg premium, and have reliable refrigeration from courier handover to last injection. The pre-filled format eliminates reconstitution steps.

Cost-Per-mg Comparison Table (2026)

Product	Format	Total mg	Price (ZAR)	Cost per mg
Body Pharm TB-500 10mg vial	Lyophilised single-peptide vial	10mg TB-500	R580.00	R58.00/mg
Body Pharm BPC-157 & TB-500 32mg pen	Pre-filled blended pen	32mg combined (BPC-157 + TB-500)	R2,499.00	~R78.09/mg (blended)

Body Pharm TB-500 10mg vial is the cheaper format at R58.00/mg, versus roughly R78.09/mg for the blended Body Pharm BPC-157 & TB-500 32mg pen. Caveat: the 32mg figure on the pen is combined BPC-157 and TB-500, not 32mg of TB-500 alone. The true per-mg cost of TB-500 inside the pen is higher than R78.09 once you separate the two actives, but the exact split is not published by the manufacturer. If you want a smaller test quantity before scaling, the Body Pharm TB-500 5mg vial is the lower-commitment option, and the Peptide Reconstitution Calculator handles the concentration maths.

How to Reconstitute the 10mg Vial: Step-by-Step

Reconstituting a Body Pharm TB-500 10mg vial takes about two minutes with bacteriostatic water, an insulin syringe, and alcohol swabs. The exact water volume depends on the concentration you want: 10 mL gives 1 mg/mL and 5 mL gives 2 mg/mL (math-based, not a manufacturer protocol).

Follow these steps in order:

1. Gather supplies: one sealed vial of bacteriostatic water, a 1 mL insulin syringe (29G–31G), two alcohol swabs, and a marker.
2. Wipe the septum: swab the rubber stopper of both the TB-500 vial and the bacteriostatic water vial. Let them air-dry for 10 seconds to reduce microbial contamination.
3. Calculate volume: decide your target concentration and use the Peptide Reconstitution Calculator to confirm the mL of bacteriostatic water for a 10mg vial.
4. Draw the water: pull the calculated volume into the insulin syringe.
5. Inject slowly down the side: angle the needle against the inner glass wall of the TB-500 vial and release the water gradually. Direct injection onto the powder cake can cause foaming and peptide shearing.
6. Swirl, never shake: rotate the vial gently between your fingers until the lyophilised powder fully dissolves. Shaking can shear peptide bonds and reduce purity.
7. Label the vial: write the reconstitution date and concentration (e.g. "12 March 2026, 2 mg/mL") on the side for tracking and compliance.
8. Store at 2–8°C: place the vial in the main body of a refrigerator, not the door, and not the freezer. Temperature fluctuations accelerate degradation.
9. Use within 28–30 days: this is a widely repeated vendor rule rather than a TB-500-specific published stability figure.

If you want a lower-commitment trial before scaling up, the Body Pharm TB-500 5mg vial follows the same procedure with half the water volume.

This is general reconstitution guidance for research use. Consult a qualified medical professional before any administration.

How Body Pharm's Third-Party COA Process Works

A Certificate of Analysis (COA) is a lab-issued document that states what's actually inside the vial: peptide identity, purity percentage, and contamination checks. For a research compound like TB-500, it's the single most useful quality signal you have before opening the seal. The label alone tells you nothing about what survived synthesis and lyophilisation.

Two assay types matter most on a peptide COA:

• HPLC (high-performance liquid chromatography), separates the contents of the sample and reports the target peptide as a percentage of total peptide content. Reputable vendors typically aim for ≥98% purity because lower purity introduces unknown contaminants.
• Mass spectrometry (MS), measures the molecular weight of the eluted peak to confirm identity. The observed mass should match the theoretical mass of the intended thymosin beta-4 fragment sequence.

Body Pharm markets its TB-500 as third-party tested, with a COA available on request through BeSkinny. The specific testing lab and batch purity figures are not published on the public product listing, so request the COA to confirm them. To request it, email BeSkinny with the batch number printed on your vial and ask for the matching COA PDF.

What I check when a COA batch lands

When I receive a COA from a supplier, I run through the same checklist every time. Does the batch number on the document match the vial in front of me? Is the testing lab named and contactable? Does the report date fall within a reasonable window of the manufacture date? Does the HPLC chromatogram show a clean dominant peak? Does the MS reading match the expected mass for thymosin beta-4 fragment? If any of those fail, the batch doesn't get listed. A mismatch signals either mislabelling or degradation during transit.

What a COA does not do

A COA confirms what's in the vial. It does not constitute SAHPRA registration, medical approval, or evidence of safety for human use. Regulatory approval requires clinical trial data that TB-500 does not yet have. TB-500 in this format is sold strictly as a research compound. A listing that advertises "lab tested" without offering a downloadable or on-request COA should be treated as a red flag rather than an oversight; request the BeSkinny COA before you buy. Transparency is the baseline for research-grade compounds.

TB-500 + BPC-157: The Recovery Stack Explained

The "Wolverine Stack" pairs TB-500 with BPC-157 because the two peptides are studied for complementary repair pathways. TB-500 (a thymosin beta-4 fragment) is researched for systemic actin upregulation and cell migration. BPC-157 is researched for localised soft-tissue, tendon, and gut repair. Researchers and community users combine them on the assumption that one covers systemic tissue turnover and the other targets the injury site directly.

The "Wolverine Stack" label itself comes from the research and fitness community rather than clinical literature. As of 2026, no large-scale human randomised controlled trial (RCT) has confirmed synergistic effects of BPC-157 + TB-500 in humans. The combination is commercially popular and anecdotally reported, but efficacy and synergy claims remain unproven.

Bundle pricing vs separate vials

Buying the Body Pharm TB-500 10mg and BPC-157 10mg together as the Wolverine Stack is priced at R1,062.00, versus R1,180.00 when purchased as separate vials. That's a saving of R118.00 (BeSkinny, 2026). For buyers who prefer a pre-mixed pen format instead of two lyophilised vials, BeSkinny stocks the BPC-157 & TB-500 32mg combination pen. Dosing flexibility is lower than with single-vial lyophilised stock.

Quick reference

• Stack rationale: TB-500 for systemic repair, BPC-157 for localised soft-tissue and joint repair.
• Evidence status: anecdotal and community-reported synergy; no large-scale human RCT confirmation as of 2026.
• Bundle price: R1,062.00 vs R1,180.00 separately, saving R118.00 (BeSkinny, 2026).
• Format choice: two lyophilised vials give dosing flexibility; the 32mg pre-filled pen trades flexibility for convenience.
• Reconstitution help: use the Peptide Reconstitution Calculator to set your concentration before drawing.
• Trial option: the Body Pharm TB-500 5mg vial is a lower-quantity entry point before stepping up to 10mg.

What TB-500 Is Studied For: Research Overview

TB-500 is a synthetic peptide fragment of Thymosin Beta-4 studied primarily for soft-tissue repair, inflammation modulation, and cell migration via actin regulation. As of 2026, the bulk of published work remains preclinical (animal models) and small-scale, with no large human RCT confirming musculoskeletal recovery endpoints.

Research areas covered in the literature

Muscle, tendon and ligament repair. TB-500 is marketed and discussed for connective-tissue recovery based on animal data and small human observations. Actin regulation supports cell migration to injury sites.

Inflammation and flexibility. Vendor and educational sources reference reductions in inflammatory signalling and improved range of motion in preclinical models. Human confirmation remains absent.

Cell migration and actin sequestration. Thymosin Beta-4's mechanism, binding G-actin and supporting cell migration to injury sites, is the most consistently cited rationale for its repair-related effects.

What the evidence does not show

No peer-reviewed human RCT identified in 2023–2026 confirms TB-500 as an effective treatment for musculoskeletal injury in humans. The randomised controlled trials of thymosin beta-4 conducted in people to date have targeted ophthalmic conditions, such as severe dry eye (phase 2) and neurotrophic keratopathy (phase 3), not connective-tissue repair. Claims of accelerated tendon healing, joint repair, or systemic recovery should be read as research hypotheses, not therapeutic outcomes.

Regulatory and use framing

TB-500 is sold in South Africa as a research compound, not a registered medicine with the South African Health Products Regulatory Authority (SAHPRA), and we could not verify any SAHPRA registration or scheduling entry for it at the time of writing. It is not approved for human therapeutic use. Note also that thymosin beta-4 and its derivatives are prohibited at all times by the World Anti-Doping Agency under class S2, so athletes in tested sport should not use it. Nothing on this page is medical advice. Buyers researching the compound should set concentrations using the Peptide Reconstitution Calculator before any handling. Those wanting a smaller starting quantity for laboratory work can consider the Body Pharm TB-500 5mg vial instead of the 10mg format.

Storage and Cold-Chain: Why It Matters

Lyophilised TB-500 is stable at room temperature before reconstitution, but once mixed with bacteriostatic water it becomes a cold-chain product with a short usable window. Handling that transition correctly is the difference between a vial that retains its labelled purity and one that degrades before the research protocol is finished.

Pre-reconstitution storage

The sealed lyophilised powder can be kept at 15–25°C if it stays dry and out of direct light. Refrigeration at 2–8°C extends shelf life further. Moisture ingress is the main risk because water exposure triggers hydrolysis of peptide bonds. The rubber stopper should not be punctured until the vial is ready for use.

Post-reconstitution storage

After mixing, the reconstituted solution should be refrigerated at 2–8°C and used within roughly 28–30 days. That figure is widely repeated by peptide vendors but is not, in my reading, confirmed by a TB-500-specific peer-reviewed stability study. Freezing is generally avoided because freeze-thaw cycles can damage peptide structure. Set your working concentration before drawing the first dose using the Peptide Reconstitution Calculator.

Why cold-chain shipping matters in South Africa

South African summer ambient temperatures routinely sit well above the 2–8°C refrigerated range. A parcel sitting in a delivery vehicle in Johannesburg or Durban can spend hours at temperatures that accelerate peptide degradation. Domestic cold-chain dispatch from a South African warehouse avoids the customs delays and uncontrolled transit conditions associated with cross-border peptide orders. If you want a smaller quantity to validate handling before scaling up, the Body Pharm TB-500 5mg vial is the lower-volume option.

How to Buy Body Pharm TB-500 10mg in South Africa

Body Pharm TB-500 10mg is R580.00 from BeSkinny, dispatched from within South Africa with discreet packaging and a COA available on request. The single-vial lyophilised format is sold strictly as a research compound.

Checkout accepts the following:

• Card payments (Visa, Mastercard) processed at checkout for immediate transaction confirmation
• EFT for buyers who prefer manual bank transfer and have time for processing delays
• Discreet local delivery from a South African warehouse, avoiding cross-border customs delays that can expose peptides to temperature fluctuations
• COA on request so you can verify the batch before opening the vial and confirm purity against the label claim

Bundle option: Recovery & Repair Stack

The Recovery & Repair Stack pairs TB-500 10mg with BPC-157 10mg at R1,062.00, a R118.00 saving against buying the two vials separately. Note that human RCT evidence for BPC-157 + TB-500 synergy remains unproven as of 2026. Treat the stack as a research protocol rather than a clinical recommendation.

Smaller quantity and further reading

If you'd rather validate handling and storage on a lower volume first, the Body Pharm TB-500 5mg vial is the trial-size option. Set your dilution before the first draw with the Peptide Reconstitution Calculator. Sold for laboratory research use only; not for human consumption.

Frequently Asked Questions

Is TB-500 legal to buy in South Africa? TB-500 is sold by BeSkinny strictly as a research compound and is not approved for human therapeutic use. We could not verify a current SAHPRA scheduling entry for it as of 2026. Confirm the regulatory position yourself before purchase because the legal landscape for research peptides can shift. The product is labelled for laboratory research only, and thymosin beta-4 and its derivatives are banned in tested sport by the World Anti-Doping Agency.

How long does delivery take? Body Pharm TB-500 10mg ships from a South African warehouse with discreet packaging. Exact courier transit times depend on your delivery address. Check the BeSkinny shipping policy at checkout for the current cut-off and estimated arrival window.

Can I use TB-500 and BPC-157 together? The combination is widely sold as a stack, including the BeSkinny Recovery & Repair bundle and pre-mixed pen blends. No large-scale human RCT has confirmed synergistic effects as of 2026. Community protocols are not medical advice.

What bacteriostatic water volume should I use? For a 10mg vial, 10 mL of bacteriostatic water gives a 1 mg/mL concentration, and 5 mL gives 2 mg/mL. These are direct dilution calculations based on the target peptide mass. Run your exact draw volumes through the Peptide Reconstitution Calculator before the first injection into the vial.

Does the vial come with needles and bacteriostatic water? The single-vial lyophilised format is the peptide only. Syringes, needles, and bacteriostatic water are sold separately. Confirm inclusions on the product listing before checkout.

What is the difference between the 5mg and 10mg vial? The 10mg vial yields twice the milligrams per vial at a lower cost-per-mg than the smaller format. This suits longer research protocols because you avoid multiple reconstitution cycles. The Body Pharm TB-500 5mg vial is the lower-commitment option for first-time handling and storage testing.

Next Steps

Request a Certificate of Analysis from BeSkinny using the batch number on your vial before opening the seal. Use the Peptide Reconstitution Calculator to set your target concentration, then follow the nine-step reconstitution protocol above. If you're new to lyophilised peptide handling, start with the Body Pharm TB-500 5mg vial to validate your storage and dosing workflow at lower volume before committing to the 10mg format.

References

1. Thymosin beta-4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine, 2005.
2. Thymosin beta-4 accelerates wound healing. Journal of Investigative Dermatology, 1999.
3. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Annals of the New York Academy of Sciences, 2010.
4. Thymosin beta-4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea, 2015.
5. 0.1% RGN-259 (thymosin beta-4) ophthalmic solution promotes healing in neurotrophic keratopathy patients: a randomized, placebo-controlled, double-masked phase III clinical trial. International Journal of Molecular Sciences, 2022.
6. The 2026 Prohibited List (International Standard). World Anti-Doping Agency, 2025.
7. South African Health Products Regulatory Authority. SAHPRA, 2026.